Abstract
Aim
To investigate the association between GCKR gene and nutritional treatment in NAFLD-related biomarkers.
Methods
This was an open-label and single-arm clinical trial in 44 overweight or obese adults with NAFLD receiving nutritional counseling for 6 months. Nutritional data, MedDietScore, clinical, biochemical, inflammatory and oxidative stress biomarkers were evaluated before and after intervention. Further, we genotyped GCKR rs1260326 and in T-allele carriers and non-Τ-carriers we assessed associations between the GCKR variant and nutritional counseling related to change in all biomarkers evaluated.
Results
Anthropometric measurements were significantly reduced after the end of the intervention in patients assigned to nutritional counseling. Liver imaging and fibrosis were significantly improved. GCKR rs1260326 T-allele frequency was 46.7%. T-carriers responded better to nutritional counseling regarding fasting blood glucose levels (mean6-0 change = −4.94 mg/dL (±9.33), p = 0.005), whereas non-T-carriers did not benefit from the intervention regarding glucose. On the other hand, levels of oxLDL decreased in the non-T-carriers group after the intervention, but not in T-carriers.
Conclusions
Our results show that GCKR rs1260326 T-allele is associated with better response of NAFLD patients to nutritional treatment regarding fasting blood glucose, but not oxLDL levels. Despite this important finding in the field of nutrigenetics, it is tricky to generalize this effect unless larger studies are conducted.
Similar content being viewed by others
References
Loomba R, Sanyal AJ (2013) The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 10:686–690
Masarone M, Federico A, Abenavoli L, Loguercio C, Persico M (2014) Non alcoholic fatty liver: epidemiology and natural history. Rev Recent Clin Trials 9(3):126–133
Dowman JK, Tomlinson JW, Newsome PN (2010) Pathogenesis of non-alcoholic fatty liver disease. QJM 103:71–83
Sevastianova K, Santos A, Kotronen A et al (2012) Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans. Am J Clin Nutr 96:727–734
Shah K, Stufflebam A, Hilton TN et al (2009) Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults. Obesity (Silver Spring) 17:2162–2168
Jin R, Welsh JA, Le NA, Holzberg J et al (2014) Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD. Nutrients 6:3187–3201
Browning JD, Baker JA, Rogers T et al (2011) Short-term weight loss and hepatic triglyceride reduction evidence of a metabolic advantage with dietary carbohydrate restriction. Am J Clin Nutr 93:1048–1052
Romeo S, Kozlitina J, Xing C, Pertsemlidis A et al (2008) Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 40:1461–1465
Anstee QM, Day CP (2013) The genetic of NAFLD. Nat Rev Gastroenterol Hepatol 10:645–655
Beer NL, Tribble ND, McCulloch LJ, Roos C et al (2009) The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Hum Mol Genet 18:4081–4088
Kitamoto A, Kitamoto T, Nakamura T, Ogawa Y et al (2014) Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits. Endocr J 61:683–689
Petta S, Miele L, Bugianesi E, Cammà C et al (2014) Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease. PLoS One 9:e87523
Tan HL, Zain SM, Mohamed R, Rampal S et al (2014) Association of glucokinase regulatory gene polymorphisms with risk and severity of non-alcoholic fatty liver disease: an interaction study with adiponutrin gene. J Gastroenterol 49:1056–1064
Chambers JC, Zhang W, Sehmi J, Li X et al (2011) Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet 43:1131–1138
Vaxillaire M, Cavalcanti-Proença C, Dechaume A, Tichet J et al (2008) The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective General French Population. Diabetes 57:2253–2257
Kalafati IP, Borsa D, Dedoussis GVZ (2014) The genetics of nonalcoholic fatty liver disease: role of diet as a modifying factor. Curr Nutr Rep 3:223–232
Santoro N, Zhang CK, Zhao H, Pakstis AJ et al (2012) Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents. Hepatology 55:781–789
Rousseaux J, Duhamel A, Dumont J, Dallongerville J et al (2015) The n-3 long-chain PUFAs modulate the impact of the GCKR Pro446Leu polymorphism on triglycerides in adolescents. J Lipid Res 56(9):1774–1780
Singh D, Das CJ, Baruah MP (2013) Imaging of non alcoholic fatty liver disease: a road less travelled. Indian J Endocrinol Metab 17(6):990–995
Angulo P, Hui JM, Marchesini G, Bugianesi E et al (2007) The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45(4):846–854
Panagiotakos DB, Pitsavos C, Arvaniti F, Stefanadis C (2007) Adherence to the Mediterranean food pattern predicts the prevalence of hypertension hypercholesterolemia diabetes and obesity among healthy adults the accuracy of the MedDietScore. Prev Med 44:335–340
International HapMap Consortium (2003) The international HapMap project. Nature 426:789–796
Jung SY, Sobel EM, Papp JC, Crandall JC et al (2016) Obesity and associated lifestyles modify the effect of glucose metabolism-related genetic variants on impaired glucose homeostasis among postmenopausal women. Genet Epidemiol 40:520–530
Yesilova Z, Yaman H, Oktenli C, Ozcan A et al (2005) Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 100:850–855
Lieber CS (2004) CYP2E1: from ASH to NASH. Hepatol Res 28:1–11
Anstee QM, Goldin RD (2006) Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 87:1–16
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report (2002). Circulation 106:3143
Acknowledgements
I.P. Kalafati and G.V. Dedoussis were funded by “Research Project For Excellence ΙΚΥ/SIEMENS”. This study was partially funded by the “Obesity and metabolic syndrome: dietary intervention with Greek raisins in NAFLD/NASH Investigation of molecular mechanisms” reviewed and approved by the Greek Secretariat for Research and Technology (Cooperation 890/2009). Additionally, this study was reviewed by Harokopio University and “Laiko” General Hospital Athens University Medical School Institutional Review Boards.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No potential conflicts of interest relevant to this article were reported.
Rights and permissions
About this article
Cite this article
Kaliora, A.C., Kalafati, I.P., Gioxari, A. et al. A modified response of NAFLD patients with non-significant fibrosis in nutritional counseling according to GCKR rs1260326. Eur J Nutr 57, 2227–2235 (2018). https://doi.org/10.1007/s00394-017-1499-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-017-1499-7